BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 11237525)

  • 21. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor.
    Rauscher FJ
    FASEB J; 1993 Jul; 7(10):896-903. PubMed ID: 8393820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
    Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WT1 splicing alterations in Wilms' tumors.
    Baudry D; Hamelin M; Cabanis MO; Fournet JC; Tournade MF; Sarnacki S; Junien C; Jeanpierre C
    Clin Cancer Res; 2000 Oct; 6(10):3957-65. PubMed ID: 11051244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the WT1 gene in Wilms' tumour.
    Haber DA; Housman DE
    Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice.
    Smith SI; Down M; Boyd AW; Li CL
    Cancer Res; 2000 Feb; 60(4):808-14. PubMed ID: 10706085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C; McGee SB; Cornwell MM
    Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis.
    Rackley RR; Flenniken AM; Kuriyan NP; Kessler PM; Stoler MH; Williams BR
    Cell Growth Differ; 1993 Dec; 4(12):1023-31. PubMed ID: 8117616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.
    Morris JF; Madden SL; Tournay OE; Cook DM; Sukhatme VP; Rauscher FJ
    Oncogene; 1991 Dec; 6(12):2339-48. PubMed ID: 1662794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
    Pritchard-Jones K; Fleming S
    Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of p21 by the Wilms' tumor suppressor gene WT1.
    Englert C; Maheswaran S; Garvin AJ; Kreidberg J; Haber DA
    Cancer Res; 1997 Apr; 57(8):1429-34. PubMed ID: 9108440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Wilms' tumors and malformation complexes].
    Hata J; Fukuzawa R; Takata A; Kikuchi H
    Nihon Rinsho; 2000 Jul; 58(7):1419-25. PubMed ID: 10921316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
    Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J
    Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene.
    Anant S; Axenovich SA; Madden SL; Rauscher FJ; Subramanian KN
    Oncogene; 1994 Nov; 9(11):3113-26. PubMed ID: 7936634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
    Mrowka C; Schedl A
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S106-15. PubMed ID: 11065340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of WT1 target gene expression in stably transfected cell lines.
    Thäte C; Englert C; Gessler M
    Oncogene; 1998 Sep; 17(10):1287-94. PubMed ID: 9771972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of possible WT1 RNA processing in primary Wilms tumors.
    Gunning KB; Cohn SL; Tomlinson GE; Strong LC; Huff V
    Oncogene; 1996 Sep; 13(6):1179-85. PubMed ID: 8808692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.